TY - JOUR
T1 - Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE
AU - Taher, Taufik R.
AU - Salzberg, Michael
AU - Morris, Margaret J.
AU - Rees, Sandra
AU - O'Brien, Terence J.
PY - 2005/9
Y1 - 2005/9
N2 - Mesial temporal lobe epilepsy (MTLE) is associated with high rates of depression and anxiety. A bidirectional causal relationship has been suggested, with these psychiatric comorbidities themselves enhancing epileptogenesis, possibly via hypercortisolemia. We examined the effects on epileptogenesis of chronic supplementation with low-dose corticosterone (CS) in the electrical amygdala kindling rat model. Adult Wistar rats were ovariectomized and implanted with bipolar electrodes into the left amygdala. After I week recovery, one group (n = 7) had CS (3 mg/100 ml - approx. 4.5 mg/kg/day) and a control group saline (n = 7) added to their drinking water, and both groups underwent twice daily electrical stimulations. Rats were culled 2 weeks after reaching the fully kindled state. A stereological optical fractionator technique was used to estimate the number of CA1 pyramidal cells in the hippocampus ipsilateral to the stimulations. Fewer stimulations were required in the CS-supplemented rats than in controls to reach the fully kindled state (32 vs 81, p < 0.03, Student's t-test) and the first Class V seizure (14 vs 57, p < 0.05). The mean after-discharge length was greater in the CS group (p = 0.03, repeated measures analysis of variance). There was no difference in the mean number of CA1 neurons (1.05 × 105 vs 1.04 × 105, p = 0.98). These data demonstrate that low-dose CS enhances epileptogenesis in this model of MTLE. This provides support for the hypothesis that chronic hypercortisolemia, as a result of stress, anxiety, and/or depression, may facilitate the development and progression of epilepsy in patients with MTLE. The lack of difference in hippocampal CA1 neurons indicates that the mechanism does not primarily involve pyramidal cell loss.
AB - Mesial temporal lobe epilepsy (MTLE) is associated with high rates of depression and anxiety. A bidirectional causal relationship has been suggested, with these psychiatric comorbidities themselves enhancing epileptogenesis, possibly via hypercortisolemia. We examined the effects on epileptogenesis of chronic supplementation with low-dose corticosterone (CS) in the electrical amygdala kindling rat model. Adult Wistar rats were ovariectomized and implanted with bipolar electrodes into the left amygdala. After I week recovery, one group (n = 7) had CS (3 mg/100 ml - approx. 4.5 mg/kg/day) and a control group saline (n = 7) added to their drinking water, and both groups underwent twice daily electrical stimulations. Rats were culled 2 weeks after reaching the fully kindled state. A stereological optical fractionator technique was used to estimate the number of CA1 pyramidal cells in the hippocampus ipsilateral to the stimulations. Fewer stimulations were required in the CS-supplemented rats than in controls to reach the fully kindled state (32 vs 81, p < 0.03, Student's t-test) and the first Class V seizure (14 vs 57, p < 0.05). The mean after-discharge length was greater in the CS group (p = 0.03, repeated measures analysis of variance). There was no difference in the mean number of CA1 neurons (1.05 × 105 vs 1.04 × 105, p = 0.98). These data demonstrate that low-dose CS enhances epileptogenesis in this model of MTLE. This provides support for the hypothesis that chronic hypercortisolemia, as a result of stress, anxiety, and/or depression, may facilitate the development and progression of epilepsy in patients with MTLE. The lack of difference in hippocampal CA1 neurons indicates that the mechanism does not primarily involve pyramidal cell loss.
KW - Amygdala kindling
KW - Corticosterone
KW - Epileptogenesis
KW - Stress
KW - Temporal lobe epilepsy
UR - http://www.scopus.com/inward/record.url?scp=27744472532&partnerID=8YFLogxK
U2 - 10.1038/sj.npp.1300709
DO - 10.1038/sj.npp.1300709
M3 - Article
C2 - 15770235
AN - SCOPUS:27744472532
SN - 0893-133X
VL - 30
SP - 1610
EP - 1616
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 9
ER -